Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.15M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ADCTADC Therapeutics SA	896,317	$1.28	$1.15M	100%	2026-06-30

ADCT

ADC Therapeutics SA

$1.15M

896,317 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 0

Stock	Transaction	Date	~6mo later
ADCTADC Therapeutics SA	Grant — · 213,900 sh	2026-06-30	—
ADCTADC Therapeutics SA	Tax $98.2K · 24,603 sh	2026-02-13	—
ADCTADC Therapeutics SA	Grant $1.14M · 285,200 sh	2026-02-13	—
ADCTADC Therapeutics SA	Tax $135.1K · 41,068 sh	2025-12-06	—

ADCTGrant

2026-06-30 · ADC Therapeutics SA

213,900

—

ADCTTax

2026-02-13 · ADC Therapeutics SA

$98.2K

—

ADCTGrant

2026-02-13 · ADC Therapeutics SA

$1.14M

—

ADCTTax

2025-12-06 · ADC Therapeutics SA

$135.1K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.